Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sp… Read more
Market Cap & Net Worth: Orthopediatrics Corp (KIDS)
Orthopediatrics Corp (NASDAQ:KIDS) has a market capitalization of $435.05 Million ($435.05 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13397 globally and #5562 in its home market, demonstrating a -8.36% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Orthopediatrics Corp's stock price $17.21 by its total outstanding shares 25278787 (25.28 Million).
Orthopediatrics Corp Market Cap History: 2017 to 2026
Orthopediatrics Corp's market capitalization history from 2017 to 2026. Data shows change from $485.10 Million to $435.05 Million (-1.30% CAGR).
Index Memberships
Orthopediatrics Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #364 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1304 of 3165 |
Weight: Orthopediatrics Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Orthopediatrics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Orthopediatrics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.90x
Orthopediatrics Corp's market cap is 1.90 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $485.10 Million | $45.62 Million | -$8.93 Million | 10.63x | N/A |
| 2018 | $881.72 Million | $57.56 Million | -$12.03 Million | 15.32x | N/A |
| 2019 | $1.19 Billion | $72.55 Million | -$13.73 Million | 16.37x | N/A |
| 2020 | $1.04 Billion | $71.08 Million | -$32.94 Million | 14.67x | N/A |
| 2021 | $1.51 Billion | $98.05 Million | -$16.26 Million | 15.43x | N/A |
| 2022 | $1.00 Billion | $122.29 Million | $1.26 Million | 8.21x | 798.35x |
| 2023 | $821.81 Million | $148.73 Million | -$20.97 Million | 5.53x | N/A |
| 2024 | $585.96 Million | $204.73 Million | -$37.82 Million | 2.86x | N/A |
| 2025 | $448.95 Million | $236.35 Million | -$39.65 Million | 1.90x | N/A |
Competitor Companies of KIDS by Market Capitalization
Companies near Orthopediatrics Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Orthopediatrics Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Orthopediatrics Corp Historical Marketcap From 2017 to 2026
Between 2017 and today, Orthopediatrics Corp's market cap moved from $485.10 Million to $ 435.05 Million, with a yearly change of -1.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $435.05 Million | -3.10% |
| 2025 | $448.95 Million | -23.38% |
| 2024 | $585.96 Million | -28.70% |
| 2023 | $821.81 Million | -18.17% |
| 2022 | $1.00 Billion | -33.63% |
| 2021 | $1.51 Billion | +45.12% |
| 2020 | $1.04 Billion | -12.22% |
| 2019 | $1.19 Billion | +34.72% |
| 2018 | $881.72 Million | +81.76% |
| 2017 | $485.10 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Orthopediatrics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $435.05 Million USD |
| MoneyControl | $435.05 Million USD |
| MarketWatch | $435.05 Million USD |
| marketcap.company | $435.05 Million USD |
| Reuters | $435.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.